Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The consensus price target hints at a 36.6% upside potential for BioMarin (BMRN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate ...

Smartleaf Asset Management LLC grew its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 111.2% in the 4th quarter, according to the company in its most recent 13F ...

While the job market is tough for life sciences professionals right now, it won’t always be. Employers must continue striving ...

The mother of a six-year-old girl with a rare neurodegenerative disease has urged health bosses to "do the right thing" amid ...

Oliver and Amelia Carroll have Batten Disease - an incurable genetic disorder that causes rapid decline in a child's ability to walk, talk and see. | ITV News Granada ...

Insiders have been trading these 5 stocks: (($SMTC)), (($BMRN)), (($YUM)), (($TNYA)) and (($AUPH)). Here is a breakdown of ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Legend Biotech (LEGN – Research Report), Oculis ...

Researchers at the RNA Institute at the University at Albany are pioneering new methods for designing and assembling DNA ...

Amarin Corporation plc AMRN reported a loss of 12 cents per share for the fourth quarter of 2024, which was wider than the ...